Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Post by Insightful1on Mar 09, 2022 11:50am
188 Views
Post# 34499654

MedX gives an update on the Health Partners announcement

MedX gives an update on the Health Partners announcementhttps://www.youtube.com/watch?v=BM2XH-1Lt5g

MedX has gone through a thorough due diligence process to secure a customer like Health Partners UK. A short pilot and when successful an opportunity to access 2 million patients through ~ 100 clinics. I though the comment that other pilots are nearing completion and should start to turn into commercial agreements was a strong statement. I have not seen any other teledermatology system in the world make this sort of announcement, perhaps MedX has sorted out their go to market strategy and that is why the share price is starting to come off the $.065 lows even during a brutal stock market. 
<< Previous
Bullboard Posts
Next >>